These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1703343)

  • 1. Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.
    van Hoek B; Wiesner RH; Ludwig J; Paya C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1442-3. PubMed ID: 1703343
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation.
    van Hoek B; Wiesner RH; Ludwig J; Gores GJ; Moore B; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1403-5. PubMed ID: 1989248
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution.
    Noack KB; Wiesner RH; Batts K; van Hoek B; Ludwig J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1448-51. PubMed ID: 1989260
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases.
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger JM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1415-6. PubMed ID: 1989250
    [No Abstract]   [Full Text] [Related]  

  • 6. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts.
    Lautenschlager I; Höckerstedt K; Mäkisalo H; Orko R; Taskinen E
    Transplant Proc; 1991 Aug; 23(4):2233-5. PubMed ID: 1714650
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome.
    van Hoek B; Wiesner RH; Krom RA; Ludwig J; Moore SB
    Semin Liver Dis; 1992 Feb; 12(1):41-50. PubMed ID: 1570550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vanishing bile duct syndrome].
    Hashimoto E; Hayashi N
    Ryoikibetsu Shokogun Shirizu; 1995; (7):574-6. PubMed ID: 8749558
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
    Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent cytomegalovirus in liver allografts with chronic rejection.
    Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
    Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
    Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
    Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation.
    Kobayashi N; Sakagami K; Takasu S; Inagaki M; Hasuoka H; Yagi T; Onoda T; Matsuno T; Saito S; Kawamura T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):635-9. PubMed ID: 1703707
    [No Abstract]   [Full Text] [Related]  

  • 17. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
    Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
    Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 19. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.